www.globalmedicalreit.com

NYSE: GMRE

Fourth Quarter 2019 Earnings Supplemental

Three and Twelve Months Ended December 31, 2019

Corporate Information and Analyst Coverage

Executive Team

Jeffrey Busch

Chief Executive Officer, Chairman and President

Alfonzo Leon

Chief Investment Officer

Danica Holley

Chief Operating Officer

Bob Kiernan

Chief Financial Officer and Treasurer

Jamie Barber

General Counsel and Corporate Secretary

Board of Directors

Jeffrey Busch

Chief Executive Officer, Chairman and President

Henry Cole

Lead Independent Director and Compensation Committee Chair

Paula Crowley

Director

Matthew Cypher, Ph.D.

Investment Committee Chair

Zhang Huiqi

Director

Zhang Jingguo

Director

Ronald Marston

Nominating and Corporate Governance Committee Chair

Dr. Roscoe Moore

Director

Lori Wittman

Audit Committee Chair

Sell-Side Analyst Coverage

Firm

Name

Email

Phone

Baird

Drew T. Babin

dbabin@rwbaird.com

610.238.6634

B. Riley FBR

Bryan Maher

bmaher@brileyfbr.com

646.885.5423

Compass Point

Merrill Ross

mross@compasspointllc.com

202.534.1392

D.A. Davidson

Barry Oxford Jr., CFA

boxford@dadco.com

212.240.9871

Janney

Robert Stevenson

robstevenson@janney.com

646.448.3028

National Securities

Gaurav Mehta

gmehta@yournational.com

212.417.8008

Stifel

Chad Vanacore

vanacorec@stifel.com

518.587.2581

Corporate Information

Corporate Headquarters

Stock Exchange Listing

Transfer Agent

Investor Relations

2 Bethesda Metro Center, Suite 440

New York Stock Exchange

American Stock Transfer & Trust Company

Evelyn Infurna - Evelyn.Infurna@icrinc.com; 203.682.8265

Bethesda, MD 20814

Ticker: GMRE

800.937.5449

4Q-2019| Earnings Supplemental

2

Select Quarterly Financial Data

(unaudited, and in thousands, except per share and unit amounts)

December 31,

September 30,

June 30,

March 31,

December 31,

As of Period End (unless otherwise specified)

2019

2019

2019

2019

2018

Market capitalization (common and OP)

$

621,135

$

449,536

$

396,858

$

370,194

$

258,601

Market price per share - common

$

13.23

$

11.40

$

10.50

$

9.82

$

8.89

Common stock and OP units outstanding

46,949

39,433

37,796

37,698

29,089

Preferred equity

$

74,959

$

74,959

$

74,959

$

74,959

$

74,959

Common equity

$

355,311

$

266,029

$

256,217

$

265,261

$

194,336

Noncontrolling interest

$

30,083

$

30,455

$

30,427

$

30,342

$

30,455

Total stockholders' equity

$

460,353

$

371,443

$

361,603

$

370,562

$

299,750

Investment in real estate, gross

$

905,529

$

830,446

$

763,601

$

668,931

$

647,550

Borrowings:

Credit Facility - revolver, gross

$

51,350

$

67,225

$

144,475

$

123,675

$

180,275

Credit Facility - term loan, gross

$

300,000

$

300,000

$

175,000

$

100,000

$

100,000

Notes payable, gross

$

39,317

$

39,352

$

39,385

$

39,418

$

39,453

Weighted average interest rate for quarter

3.87%

4.21%

4.27%

4.67%

4.48%

Debt Covenants (as defined in Credit Facility):

Leverage ratio (up to 60% allowed)

43.0%

48.8%

46.7%

39.2%

49.0%

Fixed charge coverage ratio for the quarter (1.50x minimum allowed)

2.22

2.09

2.01

1.94

1.92

Three Months Ended

Rental revenue

$

20,385

$

18,117

$

16,835

$

15,141

$

14,348

Interest expense

$

4,765

$

4,549

$

4,132

$

4,025

$

4,294

Management fees - related party

$

1,727

$

1,621

$

1,584

$

1,334

$

1,142

G&A expenses

$

1,608

$

1,681

$

1,640

$

1,606

$

1,368

Depreciation and amortization expenses

$

7,397

$

6,506

$

5,863

$

4,869

$

4,661

Operating expenses

$

2,132

$

1,362

$

1,143

$

1,323

$

992

Total expenses

$

17,677

$

15,887

$

14,418

$

13,157

$

12,547

Gain on sale of investment property

$

-

$

-

$

-

$

-

$

7,675

Net income attributable to common stockholders

$

1,212

$

770

$

904

$

528

$

7,036

Net income per share

$

0.03

$

0.02

$

0.03

$

0.02

$

0.31

Wtd. avg. basic and diluted common shares (GAAP)

37,876

35,512

34,559

27,380

22,815

FFO *

$

8,717

$

7,359

$

6,870

$

5,457

$

5,035

FFO per share and unit *

$

0.21

$

0.19

$

0.18

$

0.17

$

0.20

AFFO*

$

8,675

$

7,498

$

6,836

$

5,394

$

4,988

AFFO per share and unit*

$

0.21

$

0.19

$

0.18

$

0.17

$

0.20

Wtd. avg. common shares, OP and LTIP units

41,794

39,449

38,487

31,206

25,371

4Q-2019| Earnings Supplemental * See Page 8 for a reconciliation of non-GAAP financial measures for Funds from Operations (FFO) and Adjusted Funds from Operations (AFFO).

3

Fourth Quarter Highlights

FOURTH QUARTER 2019 AND SUBSEQUENT PERIOD HIGHLIGHTS

OPERATING HIGHLIGHTS

  • Fourth quarter 2019 total revenue of $20.5 million, increased 42.3% compared to the prior year period.
  • Quarterly net income per share of $0.03 on a diluted basis.
  • Funds from Operations ("FFO") of $0.21 per share and unit for the fourth quarter of 2019, as compared to $0.20 per share and unit for the prior year period.
  • Adjusted Funds from Operations ("AFFO") of $0.21 per share and unit for the fourth quarter of 2019, as compared to $0.20 per share and unit in the prior year period.

COMMON AND PREFERRED DIVIDENDS

  • On December 13, 2019, the Board of Directors declared:
    • $0.20 per share cash dividend to common stockholders of record as of December 26, 2019, which was paid on January 9, 2020.
    • $0.46875 per share cash dividend to holders of record as of January 15, 2020 of its Series A Preferred Stock, which was paid on January 31, 2020.
  • On March 3, 2020, the Board of Directors declared:
    • $0.20 per share cash dividend to common stockholders of record as of March 25, 2020, which is payable on April 9, 2020.
    • $0.46875 per share cash dividend to holders of record as of April 15, 2020 of its Series A Preferred Stock, which is payable on April 30, 2020.

ACQUISITION ACTIVITY

  • During the fourth quarter of 2019, the Company acquired five properties, encompassing an aggregate 185,220 leasable square feet, for an aggregate purchase price of $72.8 million with a weighted average cap rate of 7.4%.
  • From January 1, 2020 through March 4, 2020, the Company acquired three additional properties, encompassing an aggregate 246,623 leasable square feet, for an aggregate purchase price of $45.1 million with a weighted average cap. rate of 8.4%.

CAPITAL MARKETS ACTIVITY

  • Issued 6.9 million shares of common stock at $13.00 per share in a public offering, which generated $89.7 million of gross proceeds.
  • During the fourth quarter of 2019, the Company issued 0.6 million shares of common stock at an average offering price of $13.04 per share pursuant to its ATM program, generating gross proceeds of $7.6 million.

INTERNALIZATION

  • On December 17, 2019, the Board of Directors announced it has formed a special committee of independent and disinterested directors to evaluate potential management internalization transaction.

4Q-2019| Earnings Supplemental

4

Condensed Consolidated Statements of Operations

(unaudited, and in thousands, except per share amounts)

Revenue

Rental revenue

Other income

Total revenue

Expenses

General and administrative

Operating expenses

Management fees - related party

Depreciation expense

Amortization expense

Interest expense

Preacquisition fees

Total expenses

Income before gain on sale of investment property Gain on sale of investment property

Net income

Less: Preferred stock dividends

Less: Net income attributable to noncontrolling interest

Net income attributable to common stockholders

Net income attributable to common stockholders per share - basic and diluted

Weighted average shares outstanding - basic and diluted

Three Months Ended

December 31,

September 30,

June 30,

March 31,

December 31,

2019

2019

2019

2019

2018

$

20,385

$

18,117

$

16,835

$

15,141

$

14,348

67

78

45

59

28

20,452

18,195

16,880

15,200

14,376

1,608

1,681

1,640

1,606

1,368

2,132

1,362

1,143

1,323

992

1,727

1,621

1,584

1,334

1,142

5,585

5,006

4,608

3,867

3,680

1,812

1,500

1,255

1,002

981

4,765

4,549

4,132

4,025

4,294

48

168

56

-

90

17,677

15,887

14,418

13,157

12,547

2,775

2,308

2,462

2,043

1,829

-

-

-

-

7,675

$

2,775

$

2,308

$

2,462

$

2,043

$

9,504

(1,455)

(1,455)

(1,455)

(1,455)

(1,455)

(108)

(83)

(103)

(60)

(1,013)

$

$

1,212

770

$

904

$

528

$

7,036

$

0.03

$

0.02

$

0.03

$

0.02

$

0.31

37,876

35,512

34,559

27,380

22,815

4Q-2019| Earnings Supplemental

5

Condensed Consolidated Balance Sheets

(unaudited, and in thousands, except par values)

As of

December 31,

September 30,

June 30,

March 31,

December 31,

2019

2019

2019

2019

2018

Assets

Investment in real estate:

Land

$

95,381

$

86,878

$

76,831

$

68,326

$

63,710

Building

693,533

637,505

597,029

533,430

518,451

Site improvements

9,912

9,100

7,672

6,982

6,880

Tenant improvements

33,909

31,465

27,371

16,206

15,357

Acquired lease intangible assets

72,794

65,498

54,698

43,987

43,152

905,529

830,446

763,601

668,931

647,550

Less: accumulated depreciation and amortization

(56,503)

(48,731)

(41,882)

(35,771)

(30,625)

Investment in real estate, net

849,026

781,715

721,719

633,160

616,925

Cash and cash equivalents

2,765

2,815

3,216

1,844

3,631

Restricted cash

4,420

3,011

2,656

1,464

1,212

Tenant receivables

4,957

4,167

3,935

3,559

2,905

Due from related parties

50

75

-

-

-

Escrow deposits

3,417

2,865

3,518

3,296

1,752

Deferred assets

14,512

13,307

11,831

10,358

9,352

Derivative asset

2,194

-

-

-

-

Other assets

3,593

4,363

3,847

3,009

322

Total assets

$

884,934

$

812,318

$

750,722

$

656,690

$

636,099

Liabilities and Equity

Liabilities:

Credit Facility, net

$

347,518

$

363,242

$

315,691

$

219,993

$

276,353

Notes payable, net

38,650

38,651

38,652

38,652

38,654

Accounts payable and accrued expenses

5,069

5,501

4,224

3,385

3,664

Dividends payable

11,091

9,470

9,081

8,985

6,981

Security deposits and other

6,351

6,362

5,881

4,122

4,152

Due to related parties, net

1,648

1,584

1,358

1,100

1,030

Derivative liability

8,685

10,399

9,083

5,520

3,487

Other liability

2,405

2,379

2,371

2,367

-

Acquired lease intangible liability, net

3,164

3,287

2,778

2,004

2,028

Total liabilities

424,581

440,875

389,119

286,128

336,349

Equity:

Preferred stock ($77,625 liquidation preference)

74,959

74,959

74,959

74,959

74,959

Common stock

44

36

35

35

26

Additional paid-in capital

433,330

340,435

322,872

322,359

243,038

Accumulated deficit

(71,389)

(63,846)

(57,397)

(51,390)

(45,007)

Accumulated other comprehensive loss

(6,674)

(10,596)

(9,293)

(5,743)

(3,721)

Total Global Medical REIT Inc. stockholders' equity

430,270

340,988

331,176

340,220

269,295

Noncontrolling interest

30,083

30,455

30,427

30,342

30,455

Total equity

460,353

371,443

361,603

370,562

299,750

Total liabilities and equity

$

884,934

$

812,318

$

750,722

$

656,690

$

636,099

4Q-2019| Earnings Supplemental

6

4Q-2019| Earnings Supplemental

Condensed Consolidated Statements of Cash Flows

(unaudited, and in thousands)

Twelve Months Ended December 31,

2019

2018

Operating activities

Net income

$

9,588

$

14,561

Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation expense

19,066

13,644

Amortization of acquired lease intangible assets

5,569

3,625

Amortization of above market leases, net

881

688

Amortization of debt issuance costs and other

1,312

1,640

Stock-based compensation expense

3,336

2,671

Capitalized preacquisition costs charged to expense

231

110

Noncash lease expense

111

-

Gain on sale of investment property

-

(7,675)

Other

105

-

Changes in operating assets and liabilities:

Tenant receivables

(2,142)

(2,201)

Deferred assets

(5,160)

(5,811)

Other assets

(110)

(40)

Accounts payable and accrued expenses

857

1,519

Security deposits and other

2,199

2,024

Accrued management fees due to related party

584

79

Net cash provided by operating activities

36,427

24,834

Investing activities

Purchase of land, buildings, and other tangible and intangible assets and liabilities

(254,985)

(180,837)

Net proceeds from sale of investment property

-

31,629

Escrow deposits for purchase of properties

(1,372)

174

Loans made to related parties

(16)

(85)

Capital expenditures on existing real estate investments

(1,824)

(2,535)

Pre-acquisition costs

-

36

Net cash used in investing activities

(258,197)

(151,618)

Financing activities

Net proceeds received from common equity offerings

189,498

37,307

Escrow deposits required by third party lenders

(293)

(288)

Repayment of notes payable

(136)

(22)

Proceeds from Credit Facility

244,250

186,100

Repayment of Credit Facility

(173,175)

(70,725)

Payments of debt issuance costs

(1,039)

(2,811)

Redemption of LTIP Units

-

(263)

Dividends paid to common stockholders, and OP Unit and LTIP Unit holders

(29,171)

(18,964)

Dividends paid to preferred stockholders

(5,822)

(5,821)

Net cash provided by financing activities

224,112

124,513

Net increase (decrease) in cash and cash equivalents and restricted cash

2,342

(2,271)

Cash and cash equivalents and restricted cash-beginning of period

4,843

7,114

Cash and cash equivalents and restricted cash-end of period

$

7,185

$

4,843

7

Reconciliation of Funds from Operations (FFO) & Adjusted Funds from Operations (AFFO)

(unaudited, and in thousands, except per share and unit amounts)

Non-GAAP Financial Measures

FFO and AFFO are non-GAAP financial measures within the meaning of the rules of the SEC. The Company considers FFO and AFFO to be important supplemental measures of its operating performance and believes FFO is frequently used by securities analysts, investors, and other interested parties in the evaluation of REITs, many of which present FFO when reporting their results. In accordance with the National Association of Real Estate Investment Trusts' ("NAREIT") definition, FFO means net income or loss computed in accordance with GAAP before noncontrolling interests of holders of OP units and LTIP units, excluding gains (or losses) from sales of property and extraordinary items, less preferred stock dividends, plus real estate-related depreciation and amortization (excluding amortization of deferred financing costs and above-market lease amortization expense), and after adjustments for unconsolidated partnerships and joint ventures. Because FFO excludes real estate-related depreciation and amortization (other than amortization of deferred financing costs and above and below market lease amortization expense), the Company believes that FFO provides a performance measure that, when compared period-over-period, reflects the impact to operations from trends in occupancy rates, rental rates, operating costs, development activities and interest costs, providing perspective not immediately apparent from the closest GAAP measurement, net income or loss.

AFFO is a non-GAAP measure used by many investors and analysts to measure a real estate company's operating performance by removing the effect of items that do not reflect ongoing property operations. Management calculates AFFO by modifying the NAREIT computation of FFO by adjusting it for certain cash and non-cash items and certain recurring and non-recurring items. For the Company these items include: (a) recurring acquisition and disposition costs, (b) loss on the extinguishment of debt, (c) recurring straight line deferred rental revenue, (d) recurring stock-based compensation expense, (e) recurring amortization of above and below market leases, (f) recurring amortization of deferred financing costs, (g) recurring lease commissions, and (h) other items.

Management believes that reporting AFFO in addition to FFO is a useful supplemental measure for the investment community to use when evaluating the operating performance of the Company on a comparative basis. The Company's FFO and AFFO computations may not be comparable to FFO and AFFO reported by other REITs that do not compute FFO in accordance with the NAREIT definition, that interpret the NAREIT definition differently than the Company does, or that compute FFO and AFFO in a different manner.

Three Months Ended

December 31,

September 30,

June 30,

March 31,

December 31,

2019

2019

2019

2019

2018

Net income

$

2,775

$

2,308

$

2,462

$

2,043

$

9,504

Preferred stock dividends

(1,455)

(1,455)

(1,455)

(1,455)

(1,455)

Depreciation and amortization expense

7,397

6,506

5,863

4,869

4,661

Gain on sale of investment property

-

-

-

-

(7,675)

FFO

$

8,717

$

7,359

$

6,870

$

5,457

$

5,035

Amortization of above market leases, net(1)

247

229

191

219

204

Straight line deferred rental revenue

(1,492)

(1,476)

(1,472)

(1,366)

(1,345)

Stock-based compensation expense

843

868

854

771

693

Amortization of deferred financing costs and other

312

350

337

313

311

Preacquisition fees

48

168

56

-

90

AFFO

$

8,675

$

7,498

$

6,836

$

5,394

$

4,988

FFO per share and unit

$

0.21

$

0.19

$

0.18

$

0.17

$

0.20

AFFO per share and unit

$

0.21

$

0.19

$

0.18

$

0.17

$

0.20

Weighted Average Common Shares, OP and LTIP Units:

Common shares

37,876

35,512

34,559

27,380

22,815

OP units

3,143

3,143

3,143

3,145

1,968

LTIP units

775

794

785

681

588

Total Weighted Average Shares and Units

41,794

39,449

38,487

31,206

25,371

(1) The Company adopted the 2018 NAREIT FFO White Paper Restatement during the first quarter of 2019. Accordingly, amortization of above and below market leases is no longer included as a reconciling item in determining FFO.

4Q-2019| Earnings Supplemental

8

Capitalization and Dividend Summary

(unaudited, and in thousands, except per share data)

Capitalization - As of December 31, 2019

Shares/Units

Share Price

Total

Common Equity

Common Shares

43,806

$13.23

$579,553

OP Units

3,143

41,582(2)

Total Common Shares and OP Units

46,949

$621,135

Preferred

Series A Cumulative Redeemable Preferred Stock (1)

3,105

$74,959

Debt

Credit Facility, gross

$351,350

Notes Payable, gross

39,317

Total Debt

$390,667

Total Capitalization

$1,086,761

  1. The Company may redeem the Series A Preferred Stock for cash in whole or in part, on or after September 15, 2022 at a cash redemption price of $25.00 per share, plus any accrued and unpaid dividends.
  2. Calculated using common share price.

Preferred Dividends

Date Announced

Record Date

Payment Date

Dividend Amount

Dividends per Share

December 13, 2018

January 15, 2019

January 31, 2019

$ 1,455

$

0.46875

March 6, 2019

April 15, 2019

April 30, 2019

$ 1,455

$

0.46875

June 14, 2019

July 15, 2019

July 31, 2019

$ 1,455

$

0.46875

September 13, 2019

October 15, 2019

October 31, 2019

$ 1,455

$

0.46875

December 13, 2019

January 15, 2020

January 31, 2020

$ 1,455

$

0.46875

Common Dividends

Date Announced

Record Date

Payment Date

Dividend Amount

Dividends per Share

December 13, 2018

December 26, 2018

January 10, 2019

$

5,695

$

0.20

March 6, 2019

March 26, 2019

April 10, 2019

$

7,688

$

0.20

June 14, 2019

June 26, 2019

July 11, 2019

$

7,699

$

0.20

September 13, 2019

September 25, 2019

October 10, 2019

$

8,004

$

0.20

December 13, 2019

December 26, 2019

January 9, 2020

$

9,541

$

0.20

4Q-2019| Earnings Supplemental

9

Acquisitions

2019 Completed and To-Date 2020 Acquisitions

In 2019, the Company completed 18 acquisitions, encompassing an aggregate 701,936 leasable square feet for a total purchase price of $253.5 million with annualized base rent of $19.0 million at a

weighted average cap rate of 7.5%.

Leasable

Price(1)

Base Rent(2)

Capitalization

Date

Property

City, State

Square Feet

(in thousands)

(in thousands)

Rate(3)

2/28/2019

AMG Specialty Hospital

Zachary, LA

12,424

$

4,500

$

409

9.1%

3/19/2019

East Valley Gastro

Chandler, AZ

39,305

16,100

1,228

7.6%

First Quarter Total

51,729

$

20,600

$

1,637

7.9%

4/15/2019

Encompass Health Rehabilitation Hospital of Desert Canyon

Las Vegas, NV

53,260

$

21,500

$

1,504

7.0%

4/15/2019

Cobalt Rehabilitation Hospital of Surprise

Surprise, AZ

54,575

28,500

1,971

6.9%

4/15/2019

Saint Joseph Rehabilitation Institute

Mishawaka, IN

45,920

16,000

1,464

9.2%

4/15/2019

Mercy Rehabilitation Hospital Oklahoma City

Oklahoma City, OK

53,449

28,000

1,919

6.9%

Second Quarter Total

207,204

$

94,000

$

6,858

7.3%

7/12/2019

cCare

San Marcos, CA

20,230

$

11,850

$

864

7.3%

8/1/2019

East Lansing Portfolio

Lansing, MI

42,817

11,025

853

7.7%

8/5/2019

Bannockburn Medical Office

Bannockburn, IL

44,063

6,900

524

7.6%

8/6/2019

Advocate Dreyer

Aurora, IL

50,000

12,500

1,019

8.2%

8/14/2019

Mission Health

Livonia, MI

61,621

10,500

876

8.3%

8/23/2019

Arizona Center for Digestive Health

Gilbert, AZ

14,052

5,500

388

7.1%

9/26/2019

Med Express

Morgantown, WV

25,000

7,825

600

7.7%

Third Quarter Total

257,783

$

66,100

$

5,124

7.8%

10/1/2019

Steward Surgical Hospital

Beaumont, TX

84,675

$

33,600

$

2,574

7.7%

10/25/2019

St. Davis Emergency Center

Bastrop, TX

28,500

11,828

917

7.8%

10/31/2019

Eye Center of NoFL

Panama City, FL

34,624

12,900

907

7.0%

11/15/2019

Southeast Orthopedics

Jacksonville, FL

20,869

8,700

616

7.1%

12/17/2019

Indiana Eye Clinic

Greenwood, IN

16,553

5,800

409

7.1%

Fourth Quarter Total

185,220

$

72,828

$

5,423

7.4%

Fiscal Year 2019 Total/Weighted Average

701,936

$

253,528

$

19,042

7.5%

2/13/2020

Wake Forest Baptist Health

High Point, NC

97,811

$

24,750

$

1,832

7.4%

2/27/2020

Medical Associates

Clinton, IA

115,142

$

11,350

$

1,282

11.3%

3/4/2020

Ascension St. Mary's Hospital

West Allis, WI

33,670

$

9,025

$

664

7.4%

First Quarter To-Date Total

246,623

$

45,125

$

3,778

8.4%

  1. Represents contractual purchase price.
  2. December 2019 base rent or month of acquisition base rent multiplied by 12 (or actual NOI for cCare, East Lansing, Bannockburn, and Mission Health properties).
  3. Capitalization rates are calculated based on current lease terms and do not give effect to future rent escalations.

Acquisitions Under Contract

We have four properties under contract for an aggregate purchase price of approximately $67.3 million. We are currently in the due diligence period for our properties under contract. If we identify problems with any of these properties or the operator of any property during our due diligence review, we may not close the transaction on a timely basis or we may terminate the purchase agreement and not close the transaction.

4Q-2019| Earnings Supplemental

10

Portfolio Update

(as of December 31, 2019 unless otherwise stated)

Total Buildings

109

Total Leasable Square Feet

2,780,851

Total Tenants

89

Leased Occupancy

99.8%

Total Annualized Cash Rent (in thousands)

$70,447

Portfolio Rent Coverage*

4.9x

Weighted Average Cap Rate

7.9%

Weighted Average Lease Term (years)

8.8

Weighted Average Rent Escalations

2.1%

Gross Portfolio Growth Since IPO - (In Millions)

$1,000

$900

$905.5

$830.4

$800

$763.6

$700

$647.6

$668.9

$602.0

$613.0

$600

$537.3

$500

$471.5

$422.3

$400

$355.4

$314.8

$300

$206.9

$200

$124.8

$100

$0

Q3-2016Q4-20161Q-20172Q-20173Q-2017

4Q2017

1Q-20182Q-20183Q-20184Q-20181Q-20192Q-20193Q-20194Q-2019

Gross Real Estate Assets

Gross Real Estate Investments During Quarter

4Q-2019| Earnings Supplemental

*See page 17 for footnotes

11

Portfolio Update Continued

(as of December 31, 2019)

Asset Types

% of Annualized Base Rent(1)

3.2%

3.4%

3.3%

MOB Total

53.9%

1.3%

MOB

30.1%

9.1%

MOB/ASC

17.7%

MOB/Imaging/ER

6.1%

IRF

25.8%

53.9%

Surgical Hospital

9.1%

25.8%

Office

3.4%

LTACH

3.3%

Acute Hospital

3.2%

FSED

1.3%

Top 10 States

% of Annualized Base Rent (1)

Texas

21.7%

Ohio

10.4%

19.6%

21.7%

Pennsylvania

8.8%

2.9%

Arizona

8.3%

Oklahoma

7.9%

3.0%

Florida

7.8%

3.6%

10.4%

Illinois

6.0%

6.0%

8.8%

Tennessee

3.6%

7.8%

8.3%

Michigan

3.0%

7.9%

California

2.9%

Other

19.6%

Top 10 Tenants

% of Annualized Base Rent (1)

10.1%

7.8%

7.1%

5.2%

3.8%

3.7%

3.2%

2.8%

2.7%

2.5%

Encompass Memorial Health Kindred Health

OCOM

Carrus Hospital Steward Health

Pipeline Health

Curahealth

Select Medical

Prospect Health

4Q-2019| Earnings Supplemental (1) Monthly base rent as of December 31, 2019 multiplied by 12

12

Operating Metrics

Lease Expiration Schedule

(as of December 31, 2019 unless otherwise stated)

($ in thousands)

Number of

Leased

% of Total

Year

Leases

Square Feet

Leased SF

ABR

% of Total ABR

2020

3

6,753

0.2%

$

113

0.2%

2021

6

163,116

5.9%

$

3,976

5.6%

2022

12

60,887

2.2%

$

1,242

1.8%

2023

12

137,748

5.0%

$

3,990

5.7%

2024

22

244,305

8.8%

$

7,482

10.6%

2025

7

200,539

7.2%

$

5,268

7.5%

2026

14

273,263

9.9%

$

5,062

7.2%

2027

14

331,572

12.0%

$

9,970

14.2%

2028

4

66,952

2.4%

$

1,579

2.2%

2029

10

233,965

8.4%

$

6,691

9.5%

2030+

38

1,055,013

38.0%

$

25,074

35.5%

Total Leased

142

2,774,113

100.0%

$

$70,447

100.0%

Tenant Affiliation or Property Location

Category

By Rent

(A)

On Campus or Adjacent

22%

(B)

Health System Affiliated

50%

(C)

On Campus or Affiliated

58%

(D)

Rehab Hospital / LTACH

29%

(E)

Retail Center

25%

(F)

Medical Office Park

24%

(G)

National Surgical Operator

12%

(A), (B), (D), (E), (F) or (G)

95%

Tenant Credit Strength By Asset Type

Rent

% of

Coverage

Category

ABR

Ratio

Inpatient Rehab Facility (IRF)

23.73%

3.42x

Surgical Hospital (SH)

9.08%

3.97x

Acute Care Hospital

3.25%

1.28x

Long-term Acute Care Hospital (LTACH)

3.24%

3.12x

TOTAL/WEIGHTED AVERAGE

39.30%

3.35x

Medical Office Building (MOB)

22.90%

6.13x

MOB/Ambulatory Surgery Center (ASC)

13.60%

7.09x

TOTAL/WEIGHTED AVERAGE

36.50%

6.49x

All Tenants Calculated for Rent Coverage

75.80%

4.86x

Large/Credit Tenants Not Calculated

20.94%

N/A

Other Tenants Not Available

3.25%

N/A

4Q-2019| Earnings Supplemental

13

See page 17 for footnotes

Top 10 Tenant Profiles

Encompass Health (Ba3) (NYSE: EHC), headquartered in Birmingham, AL is a national leader in integrated healthcare services offering both facility-based and home-based patient care through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. With a national footprint that spans 130 hospitals and 278 home health & hospice locations in 36 states and Puerto Rico, Encompass Health is committed to delivering high-quality,cost-effective care across the post-acute continuum. Encompass Health is ranked as one of Fortune's 100 Best Companies to Work For, as well as Modern Healthcare's Best Places to Work.

Marietta Memorial Health System (MMH), (BB-) is headquartered in Marietta, OH, and is the largest health system in the Parkersburg-Marietta-Vienna MSA. The largest employer in Washington County, MMH comprises (i) two hospitals, Marietta Memorial Hospital (154-bed) and Selby General Hospital (25-bed) critical access hospital; (ii) the Belpre Campus; (iii) ten clinic outpatient service sites; and (iv) five imaging locations, and has over 2,500 employees and 211 accredited physicians.

Kindred Healthcare, LLC is a healthcare services company based in Louisville, KY with annual revenues of approximately $3.3 billion. At December 31, 2018, Kindred through its subsidiaries had approximately 35,700 employees providing healthcare services in 1,789 locations in 45 states, including 74 long-term acute care hospitals, 22 inpatient rehabilitation hospitals, 11 sub-acute units, 96 inpatient rehabilitation units (hospital-based) and contract rehabilitation service businesses which served 1,586 non-affiliated sites of service. Kindred is ranked as one of Fortune magazine's Most Admired Healthcare Companies for nine years.

Oklahoma Center for Orthopedic & Multi-SpecialtySurgery, LLC (OCOM) is based Oklahoma City, OK and affiliated with USPI and INTEGRIS, and is a leading hospital for orthopedic specialists. OCOM operates a surgical hospital with nine operating rooms and a physical therapy department, an ancillary surgery center, and multiple imaging centers in throughout Oklahoma City.

Carrus Hospital is located in Sherman, TX and provides acute rehabilitative care and long term acute care. Accredited with The Joint Commission's Gold Seal of Approval, Carrus Hospital serves Sherman, Durant, Denison, Gainesville, Denton, McKinney, Plano, Bonham, Lewisville, Carrollton, Fort Worth, Dallas, Oklahoma City and beyond.

Steward Health was formed in November 2010 by the private equity group Cerberus Capital Management ("Cerberus") to take the ownership of and turn-around a once-strugglingsix-hospital health system founded in 1985 by the Archdiocese of Boston and convert a previously non-profit system to a tax-paying operator. After a number of acquisitions, Steward today is the largest private hospital operator in the country that includes 37 community hospitals across nine states and the country of Malta serving over 800 communities, with more than 42,000 employees.

Pipeline Health is a privately‐held, community‐based hospital ownership and management company based in Los Angeles. The principals of Pipeline Health have more than 250 years of collective experience in clinical medicine, finance, hospital operations and acquisitions. Pipeline's growing business, through its affiliates, includes: Emergent Medical Associates, a leading provider of ER serving 20+ hospital sites and 900,000 patients annually; Integrated Anesthesia Medical Group, with 100 providers performing 15,000 procedures annually; Avanti Hospitals, a Los Angeles health system with four hospitals, 400+ beds and 55,000 ER visits annually; Cloudbreak, a telemedicine company with 75,000 monthly encounters in 700 hospitals; Pacific Healthworks, a physician practice management company; Benchmark Hospitalists; four community hospitals in Chicago and Dallas, and a recent addition of 22 freestanding EDs upon a merger with Adeptus Health.

Curahealth is a growing national platform currently consisted of 12 long-term acute care (LTAC) hospitals under the brand of Curahealth Hospitals and six inpatient rehabilitation facilities (IRF) under the brand of Cobalt Rehabilitation. The platform is a portfolio company sponsored by Nautic Partners, a middle-market private equity group focused on three specialties including healthcare. Nautic currently invests in six healthcare companies including Curahealth and had previously invested in and exited from 14 healthcare companies including Reliant Hospital Partners, an IRF operator that was later sold to Encompass.

Select Medical (B1) is headquartered in Mechanicsburg, PA and one of the largest operators of critical illness recovery hospitals (previously referred to as long term acute care hospitals), rehabilitation hospitals (previously referred to as inpatient rehabilitation facilities), outpatient rehabilitation clinics, and occupational health centers in the U.S. based on the number of facilities. As of December 31, 2018, Select Medical operated 96 critical illness recovery hospitals in 27 states, 26 rehabilitation hospitals in 11 states, and 1,662 outpatient rehabilitation clinics in 41 states. Select Medical's joint venture subsidiary Concentra operated 524 occupational health centers in 41 states.

Prospect Medical Holdings (B3) was Established in 1996, and has grown into a significant provider of coordinated regional healthcare services in Southern California, Connecticut, New Jersey, Pennsylvania, Rhode Island and South Central Texas. In addition to their medical groups, they own 20 acute and behavioral hospitals that are located in diverse areas within Southern California, Connecticut, New Jersey, Pennsylvania, Rhode Island and South Central Texas and maintain competitive market positions in the areas they serve. All of their facilities aim to provide a comprehensive range of services tailored to their specific communities, including partnerships with other hospitals, physicians and health plans.

4Q-2019| Earnings Supplemental

14

Real Estate Portfolio

(as of December 31, 2019, see page 17 for footnotes)

Net Leasable Square

Annualized Rent (1)

Annualized Rent Per

Property

Location

# of Bldgs

Facility Type

Feet

Lease Years Remaining

($ in 000's)

Square Foot (1)

Select Medical Hospital

Omaha, NE

1

LTACH

41,113

3.6

$1,870

$45.48

Orthopedic Surgery Center of Asheville

Asheville, NC

1

ASC

8,840

2.2

$252

$28.51

Associates in Ophthalmology

West Mifflin, PA

1

MOB/ASC

27,193

10.7

$815

$29.97

Gastro One

Memphis, TN

6

MOB/ASC

52,266

8.0

$1,346

$25.75

Star Medical Center (3)

Plano, TX

1

Surgical Hospital

24,000

16.1

$1,343

$55.96

Surgical Institute of Michigan

Detroit, MI

1

MOB/ASC

15,018

6.2

$409

$27.23

Marina Towers

Melbourne, FL

1

MOB/Img

75,899

6.2

$1,149

$15.14

Berks Physicians & Surgeons

Wyomissing, PA

1

MOB

17,000

6.6

$463

$27.24

Berks Eye Surgery Center

Wyomissing, PA

1

ASC

6,500

6.6

$248

$38.15

East Orange General Hospital

East Orange, NJ

1

MOB

60,442

6.7

$1,000

$16.54

Brown Clinic

Watertown, SD

3

MOB/Img

48,132

11.7

$750

$15.58

Northern Ohio Medical Specialists

Sandusky, OH

8

MOB

55,760

7.8

$907

$16.27

Carson Medical Group Clinic

Carson City, NV

2

MOB

20,632

3.8

$376

$18.22

Piedmont Healthcare

Ellijay, GA

3

MOB

44,162

6.5

$386

$8.74

Encompass Altoona

Altoona, PA

1

IRF

70,007

1.4

$1,747

$24.95

Encompass Mechanicsburg

Mechanicsburg, PA

1

IRF

78,836

1.4

$1,962

$24.89

Encompass Mesa

Mesa, AZ

1

IRF

51,903

4.8

$1,869

$36.01

Geisinger Specialty Care

Lewisburg, PA

1

MOB/Img

28,480

3.3

$556

$19.52

Southwest Florida Neurological & Rehab

Cape Coral, FL

1

MOB

25,814

7.1

$551

$21.35

Las Cruces Orthopedic

Las Cruces, NM

1

MOB

15,761

9.1

$369

$23.41

Thumb Butte Medical Center

Prescott, AZ

1

MOB

12,000

7.2

$393

$32.75

Southlake Heart & Vascular Institute

Clermont, FL

1

MOB

18,152

2.9

$387

$21.32

Oklahoma Center for Orthopedic & Multi-Specialty Surgery

Oklahoma City, OK

3

Surgical Hospital/ Physical

97,406

13.3

$3,642

$37.39

Therapy/ASC

Unity Family Medicine

Brockport, NY

1

MOB

29,497

10.9

$621

$21.05

Lonestar Endoscopy

Flower Mound, TX

1

ASC

10,062

6.7

$306

$30.41

Carrus Specialty Hospital

Sherman, TX

1

IRF/LTACH

69,352

17.5

$2,685

$38.72

Cardiologists of Lubbock

Lubbock, TX

1

MOB

27,280

9.7

$624

$22.87

Conrad Pearson Clinic

Germantown, TN

1

MOB/ASC

33,777

4.4

$1,518

$44.94

Central Texas Rehabilitation Clinic

Austin, TX

1

IRF

59,258

7.3

$3,060

$51.64

Texas Digestive

Fort Worth, TX

1

MOB

18,084

8.5

$453

$25.05

Albertville Medical Building

Albertville, MN

1

MOB

21,486

9.0

$498

$23.18

Heartland Clinic

Moline, IL

1

MOB/ASC

34,020

13.5

$927

$27.25

Kansas City Cardiology

Lee's Summit, MO

1

MOB

12,180

5.0

$281

$23.07

Amarillo Bone & Joint Clinic

Amarillo, TX

1

MOB

23,298

10.0

$606

$26.01

Tenant/Guarantor (2)

Select Specialty Hospital - Omaha,

Inc./Select Medical Corporation

Orthopedic Surgery Center of

Ashville/Surgery Partners

Associates Surgery Centers, LLC,

Associates in Ophthalmology, Ltd.

Gastroenterology Center of the MidSouth

Star Medical Center/Lumin Health

Surgical Institute of Michigan/Surgical

Management Professionals

Marina Towers, LLC/First Choice

Healthcare Solutions, Inc.

Berks Eye Physicians & Surgeons

Berkshire Eye

Prospect Medical Holdings, Inc.

Brown Clinic

Northern Ohio Medical Specialists

Carson Medical Group

Piedmont Mountainside Hospital, Inc.

Encompass

Encompass

Encompass

Geisinger Health

Southwest Florida Neurosurgical

Associates

Las Cruces Orthopedic Associates

Thumb Butte Medical Center/Physician

Guaranty

Orlando Health, Southlake Hospital, Vascular Specialists of Central Florida

OCOM/INTEGRIS; USPI; physician

guaranty

Unity Hospital of Rochester

Lonestar Endoscopy Center, LLC

SDB Partners, LLC

Lubbock Heart Hospital/Surgery Partners,

Inc.

Urology Center of the South/Physician

guarantees

CTRH, LLC / Kindred Health

Texas Digestive Disease Consultants

Stellis Health

Heartland Clinic

Kansas City Cardiology

Amarillo Bone & Joint Clinic

4Q-2019| Earnings Supplemental

15

Real Estate Portfolio

(as of December 31, 2019, see page 17 for footnotes)

Net Leasable Square

Annualized Rent (1)

Annualized Rent Per

Property

Location

# of Bldgs

Facility Type

Feet

Lease Years Remaining

($ in 000's)

Square Foot (1)

Tenant/Guarantor (2)

Respiratory Specialists

Wyomissing, PA

1

MOB

17,598

8.0

$413

$23.47

Berks Respiratory

Zion Eye Institute

St. George, UT

1

MOB/ASC

16,000

10.0

$408

$25.50

Zion Eye Institute

Fresenius Kidney Care

Moline, IL

2

MOB

27,173

11.3

$548

$20.17

Quad City Nephrology/Fresenius Medical

Care Holdings

Northern Ohio Medical Specialists

Fremont, OH

1

MOB

25,893

10.1

$624

$24.10

Northern Ohio Medical Specialists

Gainesville Eye

Gainesville, GA

1

MOB/ASC

34,020

10.1

$792

$23.28

SCP Eyecare Services

City Hospital at White Rock

Dallas, TX

1

Acute Hospital

236,314

18.2

$2,289

$9.69

Pipeline East Dallas

Orlando Health

Orlando, FL

5

MOB

59,644

4.2

$1,257

$21.08

Orlando Health

Memorial Health System

Belpre, OH

4

MOB/Img/ER/ASC

155,600

11.2

$5,482

$35.23

Marietta Memorial

Valley ENT

McAllen, TX

1

MOB

30,811

9.7

$448

$14.54

Valley ENT

Rock Surgery Center

Derby, KS

1

ASC

16,704

7.4

$255

$15.27

Rock Surgery Center/Rock Medical

Assets

Foot and Ankle Specialists

Bountiful, UT

1

MOB

22,335

13.8

$387

$17.33

Foot and Ankle Specialists of Utah /

physician guaranty

TriHealth

Cincinnati, OH

1

MOB

18,820

6.0

$313

$16.63

TriHealth

Cancer Center of Brevard

Melbourne, FL

1

Cancer Center

19,074

3.5

$636

$33.34

Brevard Radiation Oncology / Vantage

Oncology

Heartland Women's Healthcare

Southern IL

6

MOB

64,966

9.74

$1,188

$18.29

Heartland Women's Healthcare / USA

OBGYN Management

Prospect Medical

Vernon, CT

2

MOB/Dialysis/Administrative

58,550

11.70

$792

$13.34

Prospect ECHN / Prospect Medical

Holdings, Inc.

Citrus Valley Medical Associates

Corona, CA

1

MOB

41,803

11.0

$1,204

$28.80

Citrus Valley Medical Associates

AMG Specialty Hospital

Zachary, LA

1

LTACH

12,424

16.5

$409

$32.92

AMG Specialty Hospital

East Valley Gastroenterology & Hepatology Associates

Chandler, AZ

3

MOB/ASC

39,305

10.0

$1,228

$31.24

East Valley Gastroenterology &

Hepatology Associates/ USPI

Encompass Health Rehabilitation Hospital of Desert Canyon

Las Vegas, NV

1

IRF

53,260

5.4

$1,504

$28.24

Encompass Health

Cobalt Rehabilitation Hospital of Surprise

Surprise, AZ

1

IRF

54,575

11.0

$1,971

$36.12

Cobalt Rehabilitation

Saint Joseph Rehabilitation Institute

Mishawaka, IN

1

IRF

45,920

5.0

$1,464

$31.88

Trinity

Mercy Rehabilitation Hospital Oklahoma City

Oklahoma City, OK

1

IRF

53,449

7.7

$1,919

$35.90

Kindred/ Mercy

California Cancer Associates for Research and Excellence (cCare)

San Marcos, CA

1

MOB

20,230

7.6

$864

$42.71

California Cancer Associates for Research

and Excellence (cCare)

East Lansing Medical Office Portfolio

Lansing, MI

3

MOB/ASC

42,817

8.3

$854

$19.95

Genesis Surgery Center

Bannockburn Medical Office

Bannockburn, IL

1

MOB

44,063

6.1

$524

$11.89

Illinois Bone and Joint Institute

Advocate Dryer Clinic

Aurora, IL

1

Office

50,000

5.4

$1,019

$20.38

Advocate Dryer Clinic

Mission Health Medical Office

Livonia, MI

1

MOB

61,621

3.0

$876

$14.22

Trinity Health/ Ascension

Covenant Surgical Partners - Arizona Centers for Digestive Health

Gilbert, AZ

2

MOB/ASC

14,052

9.7

$388

$27.61

Covenant Surgical Partners

MedExpress - Urgent Care MSO

Morgantown, WV

1

Office

25,000

9.5

$600

$24.00

MedExpress - Urgent Care MSO

Steward - Medical Center of Southeast Texas

Beaumont, TX

1

Surgical Hospital

84,674

5.7

$2,574

$30.40

Steward - Medical Center of Southeast

Texas

HCA - St. David's Healthcare Partnership

Bastrop, TX

1

FSED

28,500

4.5

$917

$32.18

HCA - St. David's Healthcare Partnership

EyeSouth Partners - Eye Center South

Panama City, FL

3

MOB/ASC

34,624

14.7

$907

$26.20

EyeSouth Partners - Eye Center South

Southeast Orthopedic Specialists

Jacksonville, FL

2

MOB

20,869

14.9

$615

$29.47

Southeast Orthopedic Specialists

Indiana Eye Clinic

Greenwood, IN

1

MOB/ASC

16,553

13.4

$409

$24.71

Indiana Eye Clinic

Total Portfolio/Average

108

2,780,851

8.8

$70,447

$25.33

4Q-2019| Earnings Supplemental

16

Disclosures

(as of December 31, 2019)

Rent Coverage Ratio (see pages 11 and 13)

For purposes of calculating our portfolio weighted-average EBITDARM coverage ratio ("Rent Coverage Ratio"), we excluded credit-rated tenants or their subsidiaries for which financial statements were either not available or not sufficiently detailed. These ratios are based on latest available information only. Most tenant financial statements are unaudited and we have not independently verified any tenant financial information (audited or unaudited) and, therefore, we cannot assure you that such information is accurate or complete. Certain other tenants (approximately 3% of our portfolio) are excluded from the calculation due to lack of available financial information. Additionally, our Rent Coverage Ratio adds back physician distributions and compensation. Management believes that all adjustments are reasonable and necessary.

Real Estate Portfolio (see pages 15 and 16)

Data as of December 31, 2019.

  1. Monthly base rent at December 31, 2019 multiplied by 12 (or actual NOI for cCare, East Lansing, Bannockburn and Mission Health properties). Accordingly, this methodology produces an annualized amount as of a point in time but does not take into account future contractual rental rate increases.
  2. Certain lease guarantees are for less than 100% of the contractual rental payments.
  3. Carrus Specialty Hospital does not include 12,000 square feet of shell space.

Additional Information

The information in this document should be read in conjunction with the Company's Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and other information filed with, or furnished to, the SEC. You can access the Company's reports and amendments to those reports filed or furnished to the SEC pursuant to Section 13(a) or 15(d) of the Exchange Act in the "Investor Relations" section on the Company's website (www.globalmedicalreit.com) under "SEC Filings" as soon as reasonably practicable after they are filed with, or furnished to, the SEC. The information on or connected to the Company's website is not, and shall not be deemed to be, a part of, or incorporated into, this Earnings Supplemental. You also can review these SEC filings and other information by accessing the SEC's website at http://www.sec.gov.

Certain information contained in this package, including, but not limited to, information contained in our Top 10 tenant profiles is derived from publicly-availablethird-party sources. The Company has not independently verified this information and there can be no assurance that such information is accurate or complete.

4Q-2019| Earnings Supplemental

17

www.globalmedicalreit.com

NYSE: GMRE

INVESTOR RELATIONS

Evelyn Infurna

Evelyn.Infurna@icrinc.com

203.682.8265

Attachments

  • Original document
  • Permalink

Disclaimer

Global Medical REIT Inc. published this content on 04 March 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 04 March 2020 21:33:16 UTC